OptimizeRx Corporation (OPRX)
NASDAQ: OPRX · Real-Time Price · USD
7.15
+0.37 (5.46%)
Mar 25, 2026, 4:00 PM EDT - Market closed

OptimizeRx Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
5.13-20.11-17.57-11.440.38
Depreciation & Amortization
4.334.332.42.021.97
Stock-Based Compensation
6.9611.4713.7215.755.49
Other Adjustments
1.488.539.760.360.08
Change in Receivables
0.46-2.17-8.712.28-6.99
Changes in Accounts Payable
-2.49-0.530.20.56-0.6
Changes in Accrued Expenses
3.371.051.3-0.30.48
Changes in Income Taxes Payable
-1.07----
Changes in Unearned Revenue
0.030.3-0.07-1.231.1
Changes in Other Operating Activities
0.512.01-8.272.65-1.18
Operating Cash Flow
18.724.89-7.2410.650.73
Operating Cash Flow Growth
282.80%--1367.43%-
Capital Expenditures
-0.06-0.11-0.09-0.08-0.1
Sale of Property, Plant & Equipment
--0.01--
Purchases of Intangible Assets
0.13-0.34-0.78-0.16-0.39
Purchases of Investments
---162.78-55.93-
Proceeds from Sale of Investments
--218.71--
Payments for Business Acquisitions
---82.95-2-
Proceeds from Business Divestments
--2.54--
Investing Cash Flow
0.07-0.45-25.34-58.18-0.49
Long-Term Debt Issued
--37.73--
Long-Term Debt Repaid
-8-4-1.71--
Net Long-Term Debt Issued (Repaid)
-8-436.02--
Issuance of Common Stock
0.35--0.281.0775.54
Repurchase of Common Stock
-1.15-0.91-7.52-20.02-
Net Common Stock Issued (Repurchased)
-0.8-0.91-7.8-18.9575.54
Other Financing Activities
-----1.61
Financing Cash Flow
-8.8-4.9128.22-18.9573.92
Net Cash Flow
9.99-0.47-4.36-66.4774.16
Free Cash Flow
18.664.78-7.3310.570.63
Free Cash Flow Growth
290.56%--1589.75%-
FCF Margin
17.05%5.19%-10.24%16.93%1.02%
Free Cash Flow Per Share
0.980.26-0.430.590.04
Levered Free Cash Flow
1.76-17.0513.93-7.822.05
Unlevered Free Cash Flow
19.38-6.14-38.9-8.672.03
Updated Mar 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q